A soluble HLA ELISA for the detection of donor specific anti-HLA class
I IgG antibodies was developed and compared with microlymphocytotoxic
ity. Donor sHLA was prepared from donor blood or purified blood lympho
cytes and captured onto monoclonal antibody coated ELISA plates. After
incubation of captured HLA with test serum, bound IgG antibodies were
detected using a peroxidase-conjugated anti-human IgG antibody. Serum
samples from patients on waiting lists to receive kidney transplants
were tested by lymphocytotoxicity (AHG protocol) and/or sHLA ELISA in
four different laboratories using HLA preparations from eight organ do
nors. Concordant crossmatch results were obtained for 854 (99%) of 864
ELISA crossmatches. In contrast, concordant results were obtained for
234 (91%) of 256 lymphocytotoxicity crossmatches. Interlaboratory rep
roducibility of ELISA results was 99%. In contrast, interlaboratory re
producibility of lymphocytotoxicity assay results was 78%. Endpoint ti
trations of serum specimens containing anti-HLA antibodies demonstrate
d equivalent sensitivity of ELISA and AHG lymphocytotoxicity crossmatc
h and similar sensitivity of ELISA and flow cytometry crossmatch. Spec
imens tested positive by lymphocytotoxicity without DTT treatment but
negative with DTT treatment were tested negative by ELISA, Comparison
of lymphocytotoxicity and ELISA crossmatch results showed an agreement
of 94%. This demonstrates that detection of anti- donor HLA class I a
ntibodies by ELISA is a reliable alternative to microlymphocytotoxicit
y testing.